Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wanlin Zhang

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Journal of Virology|March 29, 2022
A Neutralizing Antibody Targeting gH Provides Potent Protection against EBV Challenge <i>In Vivo</i>Junping Hong, Ling Zhong, Qingbing Zheng, et al.
Nature Communications|June 21, 2024
A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infectionLing Zhong, Wanlin Zhang, Hong Liu, et al.
The Journal of Clinical Investigation|February 18, 2025
Asparagine drives immune evasion in bladder cancer via RIG-I stability and type I IFN signalingWenjie Wei, Hongzhao Li, Shuo Tian, et al.
Nature Communications|January 30, 2025
Tailored topotactic chemistry unlocks heterostructures of magnetic intercalation compoundsSamra Husremović, Oscar Gonzalez, Berit H Goodge, et al.
Emerging Microbes & Infections|October 10, 2024
TianTan vaccinia virus-based EBV vaccines targeting both latent and lytic antigens elicits potent immunity against lethal EBV challenge in humanized miceXinyu Zhang, Yanhong Chen, Shuhui Wang, et al.
Cell Reports. Medicine|November 22, 2023
Non-overlapping epitopes on the gHgL-gp42 complex for the rational design of a triple-antibody cocktail against EBV infectionJunping Hong, Ling Zhong, Liqin Liu, et al.
Nature|April 15, 2026
EBV strain interacts with host HLA to drive nasopharyngeal carcinoma riskYanhong Chen, Jingtong Liang, Wanlin Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2022
Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusionXiao Zhang, Junping Hong, Ling Zhong, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Journal of Virology|March 29, 2022
A Neutralizing Antibody Targeting gH Provides Potent Protection against EBV Challenge <i>In Vivo</i>Junping Hong, Ling Zhong, Qingbing Zheng, et al.
Nature Communications|June 21, 2024
A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infectionLing Zhong, Wanlin Zhang, Hong Liu, et al.
The Journal of Clinical Investigation|February 18, 2025
Asparagine drives immune evasion in bladder cancer via RIG-I stability and type I IFN signalingWenjie Wei, Hongzhao Li, Shuo Tian, et al.
Nature Communications|January 30, 2025
Tailored topotactic chemistry unlocks heterostructures of magnetic intercalation compoundsSamra Husremović, Oscar Gonzalez, Berit H Goodge, et al.
Emerging Microbes & Infections|October 10, 2024
TianTan vaccinia virus-based EBV vaccines targeting both latent and lytic antigens elicits potent immunity against lethal EBV challenge in humanized miceXinyu Zhang, Yanhong Chen, Shuhui Wang, et al.
Cell Reports. Medicine|November 22, 2023
Non-overlapping epitopes on the gHgL-gp42 complex for the rational design of a triple-antibody cocktail against EBV infectionJunping Hong, Ling Zhong, Liqin Liu, et al.
Nature|April 15, 2026
EBV strain interacts with host HLA to drive nasopharyngeal carcinoma riskYanhong Chen, Jingtong Liang, Wanlin Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2022
Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusionXiao Zhang, Junping Hong, Ling Zhong, et al.
Pageof 8